Canaccord Genuity analyst Austin Moeller downgrades Maxar Technologies (NYSE:MAXR) from Buy to Hold.
Curaleaf’s Boris Jordan: No Capital Raises Planned, Company Has $50M In Revolving Credit
Price pressure has been a common theme in this past week's round of cannabis earnings.